Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
ID05233475

Get Going After concussion Lite (GAIN Lite): A Digital Intervention to Reduce Impairing Post-concussional Mild-to-moderate Symptoms in Adults

Led by University of Aarhus · Updated on 2025-04-02

100

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

U

University of Aarhus

Lead Sponsor

H

Hammel Neurorehabilitation Centre and University Research Clinic

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to develop and evaluate a digital intervention called "Get going After concussion Lite" (GAIN Lite) for adults experiencing persistent mild-to-moderate symptoms after a concussion. The study is part of a larger initiative addressing concussion treatment in Denmark, where about 25,000 people experience concussion annually. The purpose is to test the effectiveness of GAIN Lite and to better understand how physical activity and digital behavior relate to symptom severity. Participants will be randomly assigned to one of two groups: enhanced usual care (EUC) or GAIN Lite plus EUC. EUC involves brief information from a health professional about typical recovery and advice on managing symptoms. GAIN Lite adds a digital program with self-guided e-learning videos and up to four hours of video or phone sessions with a therapist over eight weeks. The intervention starts 2 to 4 months after the concussion. During the study, participants will complete questionnaires at the start, end of treatment, and at 3 and 6 months after treatment ends to measure symptoms and daily functioning. A subgroup will use an app on their smartphone for six months to monitor digital behavior and report symptoms. Physical activity will be tracked using a device worn on the thigh to measure steps, sitting time, and sleep. The main outcome is the severity of post-concussion symptoms measured by the Rivermead Postconcussion Questionnaire.

CONDITIONS

Brief Title

Get Going After concussIonN Lite

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Concussion caused by head trauma with direct head contact as per Danish Consensus Report criteria
  • Age between 18 and 60 years at time of trauma
  • Total Rivermead Postconcussion Questionnaire score of 10-30 within 1 week before enrollment
  • Able to understand, speak, and read Danish
  • Living in Central Denmark Region
  • Identified from emergency department registers or referred by general practitioners within 2-4 months after concussion
Not Eligible

You will not qualify if you...

  • Objective neurological findings or CT scan indicating neurological disease or brain damage linked to concussion
  • Previous concussion within last 2 years with ongoing symptoms at time of current concussion
  • Severe misuse of alcohol, prescription drugs, or illegal drugs
  • Severe psychiatric or neurological disorders that prevent participation, such as bipolar disorder, autism, psychotic disorders, or multiple sclerosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 8 weeks

Participants receive either enhanced usual care, which includes information and advice from a health professional about typical recovery and adaptive illness behaviors, or the GAIN Lite digital intervention added to enhanced usual care. GAIN Lite includes self-administered e-learning videos and up to four hours of video or phone sessions with a therapist over 8 weeks.

Up to 4 video or phone sessions with a therapist during treatment

Follow-up

Duration - 6 months after treatment

Participants complete self-reported measures at the end of treatment, and at 3 and 6 months after treatment to assess symptoms and functioning. A subgroup may have digital behavior monitored via an app for 6 months and physical activity tracked with accelerometers.

Self-reported assessments at end of treatment, 3 months, and 6 months after treatment; app monitoring and physical activity assessments in a subgroup

Trial Site Locations

Total: 1 location

1

Hammel Neurorehabilitation Centre and University Research Clinic

Hammel, Deb´nmark, Denmark, 8450

Actively Recruiting

Loading map...

Research Team

S

Sedsel Pedersen, PhD student

I

Iris Brunner, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Targeted Auditory Plasticity Training to Improve Central Hea...

Mild Traumatic Brain Injury

Actively Recruiting

1 location

Brain Research Assessing Impacts of Neurophysiological Proce...

Traumatic Brain Injury

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

A remotely delivered intervention targeting adults with persisting mild-to-moderate post-concussion symptoms (GAIN Lite): a study protocol for a parallel group randomised trial.

Sedsel Kristine Stage Pedersen, Mille Møller Thastum, Lene Odgaard...

https://pubmed.ncbi.nlm.nih.gov/39456081

Novel interdisciplinary intervention, GAIN, vs. enhanced usual care to reduce high levels of post-concussion symptoms in adolescents and young adults 2-6 months post-injury: A randomised trial.

Mille Moeller Thastum, Charlotte Ulrikka Rask, Erhard Trillingsgaard Næss-Schmidt...

https://pubmed.ncbi.nlm.nih.gov/31891145

Interdisciplinary intervention (GAIN) for adults with post-concussion symptoms: a study protocol for a stepped-wedge cluster randomised trial.

Erhard Trillingsgaard Næss-Schmidt, Mille Møller Thastum, Henriette Holm Stabel...

https://pubmed.ncbi.nlm.nih.gov/35906645